NOT-CA-21-120: Notice of Early Termination of RFA-CA-21-057, "A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Not Allowed)"

Notice of Early Termination of RFA-CA-21-057, "A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Not Allowed)"

Notice Number:

NOT-CA-21-120

Key Dates

Release Date:

September 22, 2021

Related Announcements

RFA-CA-21-057 - A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform the research community about the termination of ( of the Funding Opportunity Announcement (FOA) RFA-CA-21-057, "A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Not Allowed)", effective immediately.

NCI plans to issue a another FOA

The FOA (RFA-CA-21-057) currently reads:

Part I: Overview

Expiration Date

November 20, 2021

The FOA (RFA-CA-21-057) is modified to read (in bold italics):

Part I: Overview

Key Dates

Expiration Date

Terminated, with immediate effect.

Inquiries

Please direct all inquiries to:

NCI Program Support Staff at [email protected].